precision medicine

Avastin: Good Drug, Bad Decision?

Posted by  | precision medicine, treatment

Recent news that the FDA will not approve the use of the drug Avastin for breast cancer has many patients who have benefitted questioning why.  Kimmel Cancer Center director William Nelson believes it is a perfect example of why personalized cancer medicine—getting the right drugs to the right patients—is so important. “Often in trials, drugs(...)

The Top Ten of 10

Posted by  | precision medicine, Research

The Top Ten of 10 As we look ahead to a 2011 filled with new cancer discoveries, let’s take a moment to revisit the Johns Hopkins Kimmel Cancer Center’s top advances of 2010: #1:  Personalized Cancer Medicine Becomes a Reality World renowned investigator Bert Vogelstein, M.D., and team pioneered the science that has led to(...)